136 related articles for article (PubMed ID: 34362767)
1. CD93 Blockade Stabilizes Tumor Vasculature to Improve Therapy Response.
Cancer Discov; 2021 Oct; 11(10):2368. PubMed ID: 34362767
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy.
Sun Y; Chen W; Torphy RJ; Yao S; Zhu G; Lin R; Lugano R; Miller EN; Fujiwara Y; Bian L; Zheng L; Anand S; Gao F; Zhang W; Ferrara SE; Goodspeed AE; Dimberg A; Wang XJ; Edil BH; Barnett CC; Schulick RD; Chen L; Zhu Y
Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321321
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization.
Li Y; Fu L; Wu B; Guo X; Shi Y; Lv C; Yu Y; Zhang Y; Liang Z; Zhong C; Han S; Xu F; Tian Y
Cancer Cell Int; 2023 Sep; 23(1):189. PubMed ID: 37660019
[TBL] [Abstract][Full Text] [Related]
4. Structural insight into CD93 recognition by IGFBP7.
Xu Y; Sun Y; Zhu Y; Song G
Structure; 2024 Mar; 32(3):282-291.e4. PubMed ID: 38218180
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into CD93 recognition by IGFBP7.
Xu Y; Sun Y; Zhu Y; Song G
bioRxiv; 2023 Jun; ():. PubMed ID: 37333140
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoimaging of
Liu W; Zhang C; Cao H; Shi D; Zhao S; Liang T; Hou G
Oncol Lett; 2019 Dec; 18(6):6413-6422. PubMed ID: 31819775
[TBL] [Abstract][Full Text] [Related]
8. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.
Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M
Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033
[TBL] [Abstract][Full Text] [Related]
10. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.
Nativel B; Ramin-Mangata S; Mevizou R; Figuester A; Andries J; Iwema T; Ikewaki N; Gasque P; Viranaïcken W
Immunology; 2019 Oct; 158(2):85-93. PubMed ID: 31335975
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.
Bao L; Tang M; Zhang Q; You B; Shan Y; Shi S; Li L; Hu S; You Y
Biochem Biophys Res Commun; 2016 Aug; 476(4):467-474. PubMed ID: 27255994
[TBL] [Abstract][Full Text] [Related]
12. CD93/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia.
Harhausen D; Prinz V; Ziegler G; Gertz K; Endres M; Lehrach H; Gasque P; Botto M; Stahel PF; Dirnagl U; Nietfeld W; Trendelenburg G
J Immunol; 2010 Jun; 184(11):6407-17. PubMed ID: 20439917
[TBL] [Abstract][Full Text] [Related]
13. CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche.
Chevrier S; Genton C; Kallies A; Karnowski A; Otten LA; Malissen B; Malissen M; Botto M; Corcoran LM; Nutt SL; Acha-Orbea H
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3895-900. PubMed ID: 19228948
[TBL] [Abstract][Full Text] [Related]
14. Potential of serum soluble CD93 as a biomarker for asthma in an ovalbumin-induced asthma murine model.
Park HJ; Oh EY; Park YH; Yang M; Park KH; Park JW; Lee JH
Biomarkers; 2018 Jul; 23(5):446-452. PubMed ID: 29498549
[TBL] [Abstract][Full Text] [Related]
15. CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis.
Griffiths MR; Botto M; Morgan BP; Neal JW; Gasque P
Immunology; 2018 Nov; 155(3):346-355. PubMed ID: 29923617
[TBL] [Abstract][Full Text] [Related]
16. CD93 and GIPC expression and localization during central nervous system inflammation.
Liu C; Cui Z; Wang S; Zhang D
Neural Regen Res; 2014 Nov; 9(22):1995-2001. PubMed ID: 25598782
[TBL] [Abstract][Full Text] [Related]
17. CD93 hematopoietic stem cells improve diabetic wound healing by VEGF activation and downregulation of DAPK-1.
Zafari F; Shirian S; Sadeghi M; Teimourian S; Bakhtiyari M
J Cell Physiol; 2020 Mar; 235(3):2366-2376. PubMed ID: 31549396
[TBL] [Abstract][Full Text] [Related]
18. Cell surface expression of C1qRP/CD93 is stabilized by O-glycosylation.
Park M; Tenner AJ
J Cell Physiol; 2003 Sep; 196(3):512-22. PubMed ID: 12891708
[TBL] [Abstract][Full Text] [Related]
19. CD93 is Selectively Expressed on Human Myeloma Cells but Not on B Lymphocytes.
Fakhari S; Bashiri H; Ghaderi B; Tari K; Jalili A
Iran J Immunol; 2019 Jun; 16(2):142-150. PubMed ID: 31182688
[TBL] [Abstract][Full Text] [Related]
20. An Integrated Transcriptome Analysis Reveals IGFBP7 Upregulation in Vasculature in Traumatic Brain Injury.
Wang J; Deng X; Xie Y; Tang J; Zhou Z; Yang F; He Q; Cao Q; Zhang L; He L
Front Genet; 2020; 11():599834. PubMed ID: 33505428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
